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ABSTRACT
Alzheimer′s Disease (AD) is the most common form of dementia observed in
elderly patients and has significant social-economic impact. There are many initiatives
which aim to capture leading causes of AD. Several genetic, imaging, and biochem-
ical markers are being explored to monitor progression of AD and explore treatment
and detection options. The primary focus of this thesis is to identify key biomarkers to
understand the pathogenesis and prognosis of Alzheimer′s Disease.
Feature selection is the process of finding a subset of relevant features to de-
velop efficient and robust learning models. It is an active research topic in diverse areas
such as computer vision, bioinformatics, information retrieval, chemical informatics, and
computational finance. In this work, state of the art feature selection algorithms, such
as Student′s t-test, Relief-F, Information Gain, Gini Index, Chi-Square, Fisher Kernel S-
core, Kruskal-Wallis, Minimum Redundancy Maximum Relevance, and Sparse Logistic
regression with Stability Selection have been extensively exploited to identify informa-
tive features for AD using data from Alzheimer′s Disease Neuroimaging Initiative (AD-
NI). An integrative approach which uses blood plasma protein, Magnetic Resonance
Imaging, and psychometric assessment scores biomarkers has been explored. This
work also analyzes the techniques to handle unbalanced data and evaluate the effi-
cacy of sampling techniques. Performance of feature selection algorithm is evaluated
using the relevance of derived features and the predictive power of the algorithm using
Random Forest and Support Vector Machine classifiers. Performance metrics such as
Accuracy, Sensitivity and Specificity, and area under the Receiver Operating Charac-
teristic curve (AUC) have been used for evaluation. The feature selection algorithms
best suited to analyze AD proteomics data have been proposed. The key biomarkers
distinguishing healthy and AD patients, Mild Cognitive Impairment (MCI) converters and
non-converters, and healthy and MCI patients have been identified.
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CHAPTER 1
INTRODUCTION
1.1 Motivation
Alzheimer′s disease (AD) is the most frequent form of dementia in elderly patients. It
destroys brain cells resulting in loss of memory, and cognitive and behavioral problems.
With the advent of modern medicine, the average life expectancy has been on the rise.
The percentage of population that is elderly is increasing. The effects of AD on the
patient are debilitating; it also has profound adverse impacts on our social fabric in
addition to the economic impact on families. There is currently no cure for AD: It is
imperative that we understand the origins of this disease and strive towards mitigating
the risk for future generations.
The root cause for AD is unknown; however the importance of genes in the on-
set and development of this disease is unquestioned. Early onset of AD in most cases is
inherited and has been linked to any one of a number of different single-gene mutations
on particular chromosomes. These mutations cause formation of abnormal proteins, for
example, abnormal amyloid precursor protein (APP). Imaging techniques have been de-
veloped to study the accumulation of amyloid in the brain and its correlation to genetics.
Late-onset AD is likely caused by a combination of genetic, lifestyle and environmental
factors. A genetic risk factor has been identified which appears to increase the risk
for developing this disease. Apolipoprotein E (APOE) gene comes in different forms or
alleles. People with an APOE ε4 allele are likely to develop Alzheimer′s Disease than
those who do not have an APOE ε4 [1].
Genome wide association studies have been able to identify a number of genes
which may increase the likelihood of a person developing AD. The importance of contin-
uing research in this area cannot be understated. As genetic research identifies more
risk-factors, genetic testing will become critical in identifying populations at risk. As
therapies to mitigate onset and progression of AD become available, it will be important
to identify risk populations early before clinical symptoms appear. In addition, genetic
1
studies correlating environmental factors and expression of genes, also known as epi-
genetics, will be critical in minimizing the spread of this disease.
1.2 Problem Statement
There are many initiatives which aim to capture leading causes of AD. Several genetic,
imaging and biochemical markers are being explored to monitor progression of AD and
explore treatment and detection options. The complex nature of AD calls for a multi-
pronged approach which looks at a multitude of factors as any single factor is unlikely
to be an effective biomarker. Alzheimer′s Disease Neuroimaging Initiative (ADNI), a
collaborative effort by multiple research groups was launched in 2004 to help identify
the combination of biomarkers with the highest diagnostic and prognostic power. This
initiative has helped develop optimized methods and uniform standards for acquiring
biomarker data which includes Magnetic Resonance Imaging (MRI), positron emission
tomography with Pittsburgh Compound B (PiB PET imaging), proteomics (blood pro-
tein) data, genetic variants amongst population such as Single Nucleotide Polymor-
phism (SNP), structural and metabolic imaging data on patients with AD, Mild Cognitive
Impairment (MCI) and healthy controls, and creating an accessible data repository for
the scientific community [36]. An illustrative example depicting the brain cell deteriora-
tion is shown in Figure 1.1. A key issue encountered during the search for the most
potent biomarkers is measurement technique related variability and variability due to
subject-related factors. Development of optimized and standardized techniques helps
address the measurement-technique related variability. Subject-related factors can be
multifactorial such as genetic predisposition, concurrent diseases and their treatment
and effect of AD treatments. The overarching goal is to diagnose the disease in the
earliest stage so that available therapies can be used to decelerate its progression.
The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)
is a study to discover factors which determine subsequent development of symptomatic
Alzheimer′s Disease [2]. It was launched in 2006 and over a span of 4.5 years sought to
2
study 1000+ participants which included AD and MCI patients and healthy volunteers.
It used a multidisciplinary approach with 4 research streams to investigate cognitive,
imaging, biomarkers and lifestyle factors. Volunteers underwent a screening interview,
had comprehensive cognitive testing, gave 80 ml of blood, and completed health and
lifestyle questionnaires. One quarter of the sample also underwent amyloid PET brain
imaging with Pittsburgh compound B (PiB PET) and MRI brain imaging, and a sub-
group of 10% had ActiGraph activity monitoring and body composition scanning [15].
The AIBL seeks to provide a unique data repository and sample population for study
of AD which is continuously being re-assessed to determine the predictive efficacy of
biomarkers, cognitive and lifestyle factors. The focus of this work is ADNI data.
Figure 1.1: PET Scan of Normal, MCI, and AD patients [3]
The genome consists of the organism′s entire hereditary information including
both the genes and the non-coding sequences of the DNA and RNA. Genomics is a
discipline in genetics concerned with the study of the genomes of organisms. Proteins
play a critical role in living organisms as the main components of the metabolic pathways
of cells. Proteomics is the study of proteins, in particular their structures and functions.
The proteome is the entire complement of proteins including modifications made to the
protein by the organism or the system. The study of proteomes is more complex than
genomics because unlike the organism′s genome which is constant, proteome differs
from cell to cell and with time.
Considering the rapid growth in population of the elderly, it is imperative that a
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multi-stage approach be used for screening and diagnosis. Blood-based biomarkers
have the potential to offer significant advantages as a diagnostic tool as they are a cost-
effective method of screening patients which can be followed up by more complex tests
such as neuropsychological testing, neuroimaging, etc. This research work primarily
focuses on identifying blood plasma proteins signatures. Additionally, informative genes
and MRI features have also been identified which can help in AD prognosis.
Microarrays are tools for analyzing large number of gene or protein expressions
on a small glass slide. This path-breaking technique helps in analyzing and comparing
large samples quickly, for example, studying gene expression patterns between healthy
and diseased tissues. Understanding the differences in gene and protein patterns be-
tween healthy and diseased samples is the critical first step in developing techniques to
diagnose diseases, monitor their progression and identify treatment options. The data
collected using microarray assays is analyzed using various statistical techniques such
as clustering, classification and density estimation. A key challenge for these statistical
techniques is the presence of small number of observations while the number of fea-
tures present is enormous. This calls for use of advanced feature selection algorithms.
The famous German physicist, Albert Einstein, once said Information is not
knowledge. This adage aptly fits the current scenario where acquiring and storing in-
formation is getting cheaper day by day, but it is becoming increasingly difficult to get
meaningful knowledge from that information. If the ratio of features to size of training
samples is very high, learning models tend to over-fit the training set and fail to general-
ize to unknown test data. Often the amount of training samples required to statistically
analyze such multi-dimensional data grows exponentially with the dimensionality, a phe-
nomenon commonly known as Curse of Dimensionality. Feature selection, also known
as dimensionality reduction, is a technique to reduce the dimensionality of the data by
retaining only relevant features for the statistical analysis. It is a data pre-processing
step before building a learning model. The benefits of feature selection are many fold.
Apart from alleviating the curse of dimensionality, it helps in reducing the noisy variables
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which can otherwise misrepresent the data. Even in the absence of noisy variables, it is
beneficial to remove redundant or irrelevant features for the sake of model interpretabil-
ity and efficiency of the algorithm. Extracting informative features based on the data is
a delicate task which must be done carefully to obtain robust results.
1.3 Background and Related Work
Several research studies have been focused on the use of feature selection algorithms
to analyze AD data. Ray et al. [39] identified 18 signaling proteins in blood plasma
which can classify Alzheimer′s Patients and Normal Control subjects with nearly 90%
accuracy. They were also able to predict the mild cognitive impairment patients who
may convert to AD in near future. Ravetti and Moscato [38] analyzed molecular da-
ta using a four step process which included abundance quantization, feature selection,
literature analysis and selection of a classifier algorithm which is independent of the fea-
ture selection process. Their study resulted in the identification of a 5-protein biomarker
molecular signature that achieves, on an average, a 96% total accuracy in predicting
clinical AD. In a recent study on ADNI data by Daniel et al. [25], 11 protein signatures
were identified which can predict pre-clinical AD achieving values of specificity and
sensitivity between 65% and 86%. They used a multivariate approach based on com-
binatorial optimization ((α,β)-k Feature Set Selection), which retains information about
individual participants and maintains the context of interrelationships between different
features, to identify the optimal set of biomarkers.
Traditional gene selection methods do not account for the high degree of re-
dundancy among the top ranked genes for a particular dataset. Presence of redundant
genes can reduce the representativeness of a selected gene for the targeted classes
and also increase the dimensionality of the selected genes adversely impacting the
classification/prediction performance. The input data can have redundant information,
in other words, correlated or dependent features. No additional information is gained
when these redundant features are present together. Sometimes features which are
5
not of any use by themselves can prove to be very useful when combined with other
features. Isabelle at el. have given a good discourse of relevant, redundant, correlat-
ed, and useless features [20]. Pair-wise Gene-to-gene correlation has been used by
some researchers to remove redundant genes [14]. Some issues with this approach
are the time complexity of O(N2) and the decision needed for the threshold for num-
ber of selected genes. Yu and Liu proposed an efficient way to tackle these issues
by developing a novel method which does not require setting of a threshold in deter-
mining feature redundancy and combines sequential forward selection with elimination
substantially reducing the number of feature pairs which need to be evaluated [49].
Tuv et al. [45] developed an algorithm using tree-based ensembles to generate
a compact subset of non-redundant features. They utilized Random Forest algorithms
which efficiently rank features for large data sets, and augmented the original data with
artificial contrast variables which were constructed independent from the target and uti-
lized their ranking for removing irrelevant variables from the original dataset. Serial en-
sembles were used to discover significant masking effects for redundancy elimination.
Additionally, they employed an iterative strategy which allowed for weaker predictors to
be identified after the stronger ones. Fung and Stoeckel [17] applied feature selection
techniques for classification of SPECT images of Alzheimer′s disease. They used a
linear programming formulation which incorporates proximity of features to generate a
classifier which uses the most relevant areas for classification. Their study resulted
in more robust classifiers with sensitivity considerably better than human experts. It
is assumed that the real world data is generally Sparse, i.e. the set of most informa-
tive genes is very small. To take advantage of sparsity of the data, special machine
learning techniques are required. Sparse Learning with Efficient Projection(SLEP) is a
complete package of machine learning algorithms for finding sparse representations of
data [21][32].
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1.4 Thesis Organization
Chapter 2 gives the details of the feature selection algorithms used in generating the
informative feature subset followed by model selection algorithms to measure the good-
ness of the former algorithm. Stability Selection approach, methods for handling unbal-
anced data, and performance metrics are also discussed. Chapter 3 gives the details
of the datasets, experiments, and results obtained. Chapter 4 concludes the thesis with
observations from current work and pointers to extend the work.
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CHAPTER 2
SYSTEMS AND METHODOLOGY
This chapter lists the state-of-the-art techniques assayed in identifying potential biomark-
ers for Alzheimer′s Disease. The chapter starts with a brief discussion of various tech-
niques commonly employed to prepare the data for analysis. A detailed description
of various feature selection algorithms studied is summarized in section 2.3. Stability
Selection, a procedure to ensure that the sub-feature space is stable, is described in
section 2.4. A brief summary of classification techniques is listed in section 2.5.
2.1 Data Pre-Processing
Real world data is noisy and erroneous. Tools employed in data collection can have
calibration issues which might result in missing or out of range values. Various steps
are involved in preparing the raw data for the statistical analysis [29]. This section dis-
cusses few of the common measures taken to process the data.
2.1.1 Missing Values
Missing value is defined as the absence of the information about the variable in the
given observation. Missing data can adversely impact the data analysis and result in
erroneous conclusions. Imputation methods can be used to estimate missing values.
Another approach is to discard the samples with missing values. The latter approach
has been employed in this thesis.
2.1.2 Handling Unbalanced Data
This is one of the main issues in data classification. Unbalanced data refers to unequal
number of observations in different classes, in other words, the observed data is biased
towards the majority class. A number of approaches have been used to evaluate imbal-
anced data such as random over-sampling with replacement, random under-sampling,
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and directed over-sampling. Sampling methods are often applied to the data used to
build the learning model. The two sampling methods used in this work are discussed
here.
2.1.2.1 Over Sampling
Over-sampling relies on random replication of minority samples to achieve balance in
the class/category distribution. Over-sampling increases computational burden for large
datasets.
2.1.2.2 Under Sampling
Random under-sampling aims to achieve balance by random elimination of some major-
ity class samples. The downsides of this approach are the risk of discarding potentially
important data and the loss of randomness of the sample distribution [28].
2.1.3 Feature Selection
There are many advantages of feature selection. It is one of the most fundamental da-
ta pre-processing steps. Section 2.3 discusses the commonly used feature selection
methods.
2.1.4 Data Normalization
It is important to distinguish between natural variations in gene expression levels and
variations induced by measurement noise. This technique is increasingly used to an-
alyze microarray data to remove systematic effects and improve signal to noise ratio.
Normalization helps pre-process the data to better suit the requirements of the algo-
rithm. There are several techniques which can be employed to normalize the data. In
mean normalization, the data is normalized so that the average of the distribution is ze-
ro. In unit normalization, the data is normalized such that the standard deviation is one.
Generally, normalization techniques are used to make the values, which are measured
using different scales, comparable. It is also known as Feature Scaling. Classification
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algorithms like SVM using Gaussian Kernel require all features to be on same scale. For
a given data distribution, X ∈ RMxN , feature scaling for ith data point and jth feature
is computed using the formulae:
• Min-Max Normalization,
z
(j)
i =
x
(j)
i − x(j)min
x
(j)
max − x(j)min
(2.1)
• Z-score Normalization,
z
(j)
i =
x
(j)
i − µ(j)
σ(j)
(2.2)
where x(j)min is the minimum, x
(j)
max is the maximum, µ(j) is the mean and σ(j) is the
standard deviation of the jth feature vector.
2.2 Dataset Generation
The given data is partitioned into disjoint training and testing subsets to determine the
efficacy and the generalization capability of the model learned. The learning model is
built on training set and its power is determined on test or validation set. The train-test
split ratio used is usually 7:3 or 9:1. There are various methods to generate train-test
set. This section discusses the commonly used techniques.
2.2.1 Cross Validation
This is a common approach employed in classification problems. In this strategy, the
data is repeatedly divided into training and test sets. Neither the training nor the testing
sets should overlap in any of the iterations so that each data point is in the test set
atleast once. The performance of the classifier is determined using various averaging
techniques. In this work, simple averaging method is used. The following subsections
give a brief account of the different cross validation approaches.
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2.2.1.1 k-fold Cross Validation
The data is evenly partitioned into k-folds. A test set is generated using one of the folds
and remaining k-1 folds are used as training data. This process is repeated k times,
such that each of the k folds is used exactly once as the test set. This approach has
been used in this thesis.
2.2.1.2 Leave-One-Out Cross-validation
This is a special case of k-fold cross validation, where k=N (N is the number of data
points). Subsequently, the model is trained on (N − 1) data points and there are N
rounds of training the model. This is indeed a computationally expensive procedure
and is better suited for smaller datasets.
2.2.2 Random Subsampling
Random Subsampling is the most common approach to generate train-test datasets.
Training data points are randomly selected and the remaining data points are used for
test set. It is common to generate atleast 10 such datasets; these datasets can overlap
and some data points will never be selected in either training or testing or both. The trick
is to generate enough datasets, such that each data point is used atleast once. This
approach is used in the thesis with 10 different train-test datasets using 9:1 train-test
split ratio.
2.3 Feature Selection Algorithms
Feature selection (FS) is an important tool in Machine Learning. FS algorithms can
be categorized into filter, wrapper, and embedded methods based on the criteria used
for selecting the prominent features. Filter methods are based on ranking the features,
usually analyzing each feature individually, using test statistics or by assigning them d-
ifferent weights depending upon their usefulness in separating the two classes. Due to
the simplicity and deployment efficiency, filter methods are most commonly employed.
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Wrapper methods are so called as they wrap any classification technique to select a
sub-set of features by exhaustively searching the feature space. This technique can be
computationally expensive with risk of overfitting the data. Embedded techniques are
similar to wrapper methods, but unlike wrapper approach they use specific classifica-
tion models. While most FS algorithms are designed to work on classification problems,
some can be extended to perform regression analysis as well. In classification prob-
lems, the FS algorithms can further be classified into three categories: supervised, un-
supervised, and semi-supervised, depending upon the input data, if the data is labeled,
unlabeled or partially labeled respectively.
In this work, supervised classification based feature selection algorithms which
utilize filter methods are examined. Features are assumed to be independent and i-
dentically distributed (i.i.d), i.e. no redundant features. The matlab code for the FS
algorithms is taken from ASU Feature Selection Repository [50] unless otherwise not-
ed. This section gives a brief overview of various feature selection algorithms studied
in this work.
2.3.1 Student′s t-test
It is a statistical hypothesis test in which the test statistic follows a Student′s t-distribution
if the null hypothesis, denoted by H0, is supported. The alternative hypothesis, denoted
by H1, checks for the condition that H0 does not hold. This test is suited for distributions
which are smaller in size, are symmetric to normal distribution, and their variance is
unknown. There are three types of t-test:
• One Sample t-test compares the sample mean with the known population mean
or any fixed value. The null hypothesis states that the sample mean and the
population mean or the given fixed value are equal.
• Unpaired t-test compares two samples which are independent and identically dis-
tributed. For example, one sample is drawn from the population of control subjects
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and another sample is drawn from the population of subjects with illness. The null
hypothesis states that the two samples have equal means and equal variances.
• Paired t-test compares two samples which are dependent. For example, the sam-
ples comprising same subjects before and after treatment. The null hypothesis
states that the two samples have equal means.
Let X and Y be the samples drawn from a population, then the test statistic
(t-score) is defined by the equation:
t =
[x− y]
SE
(2.3)
where SE, the standard error of the sampling distribution is computed as:
SE =
√
[(
s2x
n
) + (
s2y
m
)]
x and y are the sample means,n and m are the sample sizes, and sx and sy are the
sample standard deviations of X and Y respectively. DF, the Degrees of freedom is
given by the equation:
DF =
[( s
2
x
n ) + (
s2y
m )]
2
[
(
s2x
n
)2
n−1 ] + [
(
s2y
m
)2
m−1 ]
Figure 2.1: Acceptance and Rejection regions of a two-tailed Hypothesis Test. P-value
lies in the Rejection region.
P-value is defined as the probability of observing a sample statistic as extreme
or more extreme as test statistic under the null hypothesis. It is computed using a table
of values from Student′s t-distribution given a t-score and DF. The null hypothesis is
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rejected if P-value is less than or equal to the significance level, denoted by α ≤0.05.
The features are ranked in ascending order of P-values. A one-tailed t-test tests the
statistical significance in the one direction of interest according to the alternative hy-
pothesis. This contrasts with a two-tailed t-test, in which the null hypothesis will be
when the value of the test statistic is either sufficiently small or sufficiently large. In
this work, unpaired, two-tailed t-test is used. The MathWork′s matlab T-Test function is
used for this algorithm [19].
2.3.2 Relief-F
Relief-F is an extension of one of the most successful feature subset selection algo-
rithms, Relief [26] based on relevance of features. The majority of feature selection
algorithms estimate the quality of a feature based on its conditional independence upon
the target class. Relief algorithm assesses the significance of a feature based on its
ability to distinguish the neighboring instances. Let X be the sample distribution with
M training data points in N dimensional feature space. To find the relevant feature
subset of size n N , Relief algorithm proceeds as follows:
(a) Initialize the weight vectorWNx1 to zero.
(b) Select a triplet of data points: xi, xsame, and xother
where xi is a randomly selected instance, xsame is a near-hit data point, a nearest
neighbor which belongs to the same class as xi, and xother is a near-miss data
point, a nearest neighbor which belongs to different class than xi. N -dimensional
euclidean distance is used to find xsame and xother.
(c) The difference between a feature value from the two instances is computed as:
If the feature has continuous values:
diff(x1(f), x2(f)) =
(x1(f)− x2(f))
nc
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where nc is normalization unit to get diff value in [0,1] interval.
If the feature has categorical values:
diff(x1(f), x2(f)) =
 0, if x1(f) = x2(f)1, otherwise
(d) For every f th feature:
W(f) =W(f)− diff(xi(f), xsame(f))2 + diff(xi(f), xother(f))2 (2.4)
The underlying principle behind this equation is that if diff(xi(f), xsame(f)) is large,
then this feature f distinguishes data points within the same class. Such a feature
is of no use and hence its weight should be reduced.
Whereas if diff(xi(f), xother(f)) is large, then this feature f distinguishes the data
points from two different classes which serves the feature selection problem formu-
lation well. Thus, the difference is added to increase the weight of such features.
(e) Repeat steps (b) and (d) for all instances of X .
(f) Compute the average weight of each feature:
Wavg = W
M
(g) Wavg is sorted in descending order and top n features are returned as the rele-
vant feature subset. Another way to extract the informative features is to provide a
threshold τ such that anyWavg(f) < τ will be discarded from the feature subset.
Relief-F algorithm improves Relief algorithm by introducing k-nearest neighbors
from each class [40]. With this new approach, step(b) will give 2k+1 data points and
in step(d), diff(., .) value is averaged over all k diff(., .) values. Choosing an optimal
value of k is tricky; many values should be tried and the value which best generalizes
the validation set should be used. A general rule of thumb is to start with k=10. This
algorithm has been extended to handle incomplete data and multi-class problems [27].
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2.3.3 Fisher Kernel Score
This is a comparatively new feature selection approach using Fisher Kernel [23] as
the similarity measure between two data points. The key idea is to incorporate the
goodness of generative and discriminative models. For example, a generative model,
such as Naive Bayes or Hidden Markov Model, is trained on the data to generate a
Fisher Kernel which is used in a kernel based discriminative model such as Support
Vector Machine. Fisher Kernel is defined as:
K(xi, xj) = U
T
xiI
−1Uxj (2.5)
where xi and xj are the data points, I is the Fisher Information Matrix, and Ux is the
Fisher Score given by the equation:
Ux = ∇θlogP (x|θ)
where x is the data point, θ is the vector of parameters, logP (x|θ) is the log-likelihood
of x with respect to the probability model given θ. ∇θ is the gradient operator.
Jaakkola et al. [22] applied the method to detect remote protein homologies
and showed the method works well in classifying protein domains by SCOP (Structural
Classification of Proteins) superfamily. Fisher Kernel is more popular in web mining and
speech recognition domains than in biomedical data analysis.
2.3.4 Gini Index
Gini Index, also known as Gini Coefficient or Gini Ratio, measures the inequality in the
frequency distribution values. Its value lies between [0, 1], where a coefficient of 0 in-
dicates that all values of the distribution are the same and a coefficient of 1 indicates
maximal inequality. This statistical measure of dispersion is commonly used to measure
wealth or income inequality. It can be applied to various other fields as well. Mathemat-
ically it is defined as the ratio of the areas within the Lorenz curve. Gini Index is given
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by the equation:
G =
A
(A+B)
(2.6)
where A is the area above Lorenz curve and B is the area below it as shown in Figure.
It can also be computed using the formula given by Angus Deaton:
G =
N + 1
N − 1 −
2
N(N − 1)µ(
n∑
i=1
PiXi) (2.7)
where N is the size of the population, µ is the mean, and Pi is the rank P of person i
with income X.
Figure 2.2: Graphical Representation of Gini Index [3]
2.3.5 Information Gain
Information Gain (IG) is also known as information divergence, Kullback-Leibler diver-
gence, or relative entropy. Information gain is commonly used as a surrogate for ap-
proximating a conditional distribution in classification setting [13]. Let X ∈ RMxN be
the training set with M data points and N dimensions, and Y ∈ RMx1 be the class
label with c discrete values such that Y = {y1, y2, ..., yc} and yi 6= yj∀i, j ∈ [1, c]. Let
A ∈ RNx1 be the set of attributes of X . An attribute xa ∈ A can take k possible values
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such that xa = {v1, v2, ..., vk}. Both Y and xa are assumed to be discrete. IG measures
the reduction in entropy in moving from a prior distribution P (Y ) to a posterior distribu-
tion P (Y |xa). In simpler words, it represents the reduction in uncertainty of predicting
Y given xa. Information Gain is given by:
IG(Y |xa) = H(Y )−H(Y |xa) (2.8)
where H(Y ) and H(Y |xa) are entropy functions defined as:
H(Y ) = −
c∑
i=1
P (Y = yi)logP (Y = yi)
H(Y |xa) = −
k∑
i=1
P (xa = vi)P (Y |xa = vi)
An attribute with higher value of IG is considered more relevant and is assigned a higher
weight. This is an asymmetric method, i.e. IG(Y |xa) 6= IG(xa|Y ), and is not suitable
for attributes which can take large number of discrete values (for example, when k is a
large number) as it might cause overfitting problems.
2.3.6 Kruskal Wallis
Kruskal-Wallis is a non-parametric, rank based test to determine if the samples belong
to the same distribution. It is based on one-way analysis of variance and does not
assume a normal distribution. Its null hypothesis states that the populations from which
the samples are drawn have same median. It can compare more than 2 groups, and is
an extension of Mann-Whitney U test which analyzes a pair of sampling distributions.
The most relevant feature is given a rank of 1, the second most relevant feature is
ranked 2; similarly all N features are assigned ranks from 1 to N . Some information
can get lost in the process of ranking the features [34]. The test statistic is given by:
K = (N − 1)
∑g
i=1 ni(ri − r)2∑g
i=1 ni
∑ni
j=1(rij − r)2
(2.9)
where ni is the number of observations in the group i,
rij is the rank (among all observations) of observation j from group i,
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N is the total number of observations across all groups,
ri =
∑ni
j=1 rij
ni
, and
r = 12(N + 1) is the average of all the rij .
Simplifying the denominator of Equation 2.9 we get:
K =
12
N(N + 1)
g∑
i=1
ni(ri)
2 − 3(N + 1) (2.10)
If the test statistic results are significant, then at least one sample is different from the
rest samples; otherwise no difference exists between the samples. Repeated tests can
be performed to exactly determine which of the two sample pairs are different. Due to
high computational power required for the test, exact probabilities upto 105 samples are
available [42][34].
2.3.7 Chi-Square Test
The Chi-Square (χ2) test is a statistical test performed on samples that follow χ2 distri-
bution, a special case of gamma distribution. This distribution has the following proper-
ty:
• It is continuous, asymmetrical, skewed to right distribution, and has k degrees of
freedom such that k = N − 1, where N is the sample size.
• The mean of the distribution is equal to the degrees of freedom (k).
• The variance is twice the degrees of freedom (2k).
• It approaches normal distribution as value of k increases.
• The χ2 distribution is widely used in χ2 test to compute goodness of fit, indepen-
dence of criteria, and estimating confidence interval and standard deviation.
In feature selection, χ2 test for independence is employed to determine whether
the outcome is dependent on a feature. The null hypothesis states that the occurrences
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Figure 2.3: Probability Density Function for a family of χ2 Distributions
of the outcomes of an observation are statistically independent. Given a feature with r
distinct values and c possible outcomes, a contingency table is formed with r rows and
c columns. Each cell (i, j) of the table, where 1 ≤ i ≤ r and 1 ≤ j ≤ c, is filled with the
observed frequency, Oij , number of samples with ith feature value and jth outcome.
The test statistic is defined as:
χ2 =
r∑
i=1
c∑
j=1
(Oij − Eij)2
Eij
(2.11)
Eij is the expected frequency given by:
Eij =
(
∑r
nr=1
Onrj)(
∑c
nc=1
Oinc)
N
where N is the sample size and the degrees of freedom k = (r−1)(c−1). There must
be atleast 5 observations per cell.
P-value is the probability of obtaining a test statistic as extreme as the observed
value under null hypothesis. Given χ2 test statistic and k, P-Value is computed using
Chi-Square Distribution table. The null hypothesis is rejected if P-value is less than the
specified significance level α, which is often ≤ 0.05.
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Rejecting the hypothesis makes the result statistically significant and confirms
the dependence of the outcome on the feature value.
2.3.8 Minimum-Redundancy-Maximum-Relevance (mRMR)
Minimum-Redundancy-Maximum-Relevance selection (mRMR) selects feature subset
according to the maximum statistical dependency criterion based on mutual information
as proposed by Peng et al. [37]. It selects the features which are highly correlated
to the class variable (Maximum-Relevance), but are mutually far away from each other
(Minimum-Redundancy). Maximum relevance of a feature subset S for a class c is given
by
max D(S, c), D =
1
|S|
∑
xi∈S
I(xi; c)
and, minimum redundancy condition of all the features in S is given by
min R(S), R =
1
|S|2
∑
xi,xj∈S
I(xi;xj)
The mRMR combines the two measures and optimizes them simultaneously:
max Φ(D,R),Φ = D −R
Φ = max
s
[
1
|S|
∑
xi∈S I(xi; c)− 1|S|2
∑
xi,xj∈S I(xi;xj)
]
(2.12)
where I(xi; c) or I(xi;xj) represents the mutual information. For any two univariate
random variable x and y, mutual information is defined in terms of their probabilistic
density function as:
I(x; y) =
∫ ∫
p(x, y)log
p(x, y)
p(x)p(y)
dxdy
Similarly, for multivariate random variables Sm and target class c:
I(Sm; c) =
∫ ∫
p(Sm, c)log
p(Sm, c)
p(Sm)p(c)
dSmdc
Correlation score or distance/similarity scores can be used instead of mutual informa-
tion. mRMR is a very robust approach but, in certain pathological scenarios, it fails
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to evaluate the worth of the feature which is useless by itself but is very useful when
combined with other features. This is due to inability to measure interaction between
the features [9].
2.3.9 Sparse Logistic Regression
This FS algorithm is an example of filter method with regularization term. The guiding
principle is to use regularization in Logistic loss function such that the informative fea-
tures distinguishing the class are given more weight and other irrelevant features are
given close to zero weight [31]. Let f(θ, b) be the logistic loss function, θ is the set of
parameters or weight vector and b is the bias term. The `1-norm regularized logistic
loss is defined as:
min f(θ, b) +
λ
2
||θ||1 (2.13)
where λ is the regularization parameter. `1-norm is known to induce sparsity [16]. The
matlab code is taken from SLEP package [32]. Logistic Regression is discussed in de-
tail in a subsequent section.
2.4 Stability Selection
It is a method based on a combination of subsampling and feature selection tech-
niques to improve feature extraction and structure estimation [35]. A bootstrap sample,
XB ∈ RKxN , is obtained from the original data matrix X ∈ RMxN using sampling with
replacement technique. The approach is known as Bootstrap sampling. When K = M ,
the expected number of unique samples is given by:
(1− 1
e
) ≈ 63.2%
In practice, 500 to 1000 bootstrap samples are generated. Sparsity inducing feature
selection method is applied to each bootstrap sample with a set of regularization pa-
rameters. Frequency of a feature being selected (i.e. its weight is not zero) in each
bootstrap run is maintained for all regularization parameters. The maximum selection
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frequency of the feature, also known as the probability of the feature over its stability
path, is computed. Features are ranked in order of decreasing probability.
In this work, Sparse Logistic Regression and 1000 bootstrap samples (with
K = M ) are used with 10-12 regularization parameters such that the smallest regular-
ization parameter selects 60% to 80% features and the largest regularization parameter
selects 5% to 10% features.
2.5 Classification
Classification is a supervised learning method where a classifier is learned from the
labeled training data and is used to identify the correct category of the new (unlabeled)
instances. In binary classification data points belong to either of the two classes. In mul-
ticlass classification problems, the instance can belong to one of the several classes.
This thesis focuses on binary classification.
(a) Linearly Separable (b) NonLinearly Separable
Figure 2.4: Different types of association between binomial data in 2-D plane
For a given training matrix X ∈ RMxN and corresponding label vector Y ∈
RMx1, the classification function is defined as:
f(
−→
θ ,−→x )
where
−→
θ is the set of parameters or weight vector, learned from labeled training data;
−→x is a feature vector for the ith sample; f(−→θ ,−→x ) can be as simple a dot product or
can be as complex as a kernel function.
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Real world data can be linear or non-linear; Figure 2.4 illustrates these two cas-
es in a 2-D plane. Classifiers can be divided into two categories: linear classifiers, which
use linear combination of parameters and non-linear classifiers, which use non-linear
combination of the parameters. Regularization term is often added to the objective func-
tion to prevent overfitting. This section discusses the commonly used classifiers.
2.5.1 Logistic Regression
Logistic Regression is a classification technique using linear discriminative model to
maximize the quality of output on training data. For a two class (binomial) classification
problem, it assigns a probability to class labels using the following logistic function:
hθ(x) = P (y = 1|x; θ) = 1
1 + exp−θT x
(2.14)
Figure 2.5: Standard Logistic (Sigmoid) Function Curve [3]
hθ(x) ∈ [0, 1], is the estimated probability that the class label is positive, given
x, and parameterized by θ. If hθ(x) ≥ 0.5, the class label is positive otherwise it is
negative, as illustrated in Figure 2.5. The cost (also known as logistic loss) function for
any ith sample is defined as:
Cost(hθ(x
(i)), y) =
 −log(hθ(x
(i))) if y = 1
−log(1− hθ(x(i))) if y = 0
The objective function for Logistic Regression is defined as:
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min
θ
J(θ) = − 1
m
m∑
i=1
[
y(i)log(hθ(x
(i))) + (1− y(i))log(1− hθ(x(i)))
]
+
λ
2m
n∑
j=1
θ2j
where λ is the regularization parameter and λ2m
n∑
j=1
θ2j is the regularization term. In
general, regularization term can be written as λ2m ||θ||p where p represents the vector
norm. `1-regularized norm is known to induce sparsity [16] and is preferred for sparse
solutions. This approach can be extended to multiclass classification problems. In this
work, `1-regularized norm and binomial Logistic Regression is used.
2.5.2 Support Vector Machine (SVM)
This is a supervised classification technique using discriminative linear models. Each
data point is assigned to one and only one class. SVM constructs a hyperplane with the
largest margin, hence it is also known as Large Margin or Maximum Margin Classifier.
The equation of hyperplane dividing the two classes is given by:
θTx− b = 0 (2.15)
where yi ∈ {−1, 1}, b||θ|| is the offset of hyperplane from the origin,
−→
θ is perpendic-
ular to the hyperplane, and θx is the dot product between θ and x. The equations of
hyperplanes bounding the dividing hyperplane on either side are given by:
θTx− b = 1 and θTx− b = −1 (2.16)
The hyperplanes represented by equations 2.15 and 2.16 are illustrated in Fig-
ure 2.6. The distance between the hyperplanes defined in Equation 2.16 is 2||θ|| . In
order to maximize this distance, ||θ|| must be minimized. This can be converted into
a quadratic optimization problem and objective function of support vector machine is
given by:
min
||θ||2
2
subject to the constraint: yi(θxi − b) ≥ 1 for any i, 1 ≤ i ≤ m
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(a) SVM Classifier
Figure 2.6: SVM Classifier in a 2-D plane; θ is represented by w here [3]
Large margin lowers the generalization error of the classifier [6]. Only a subset
of training vectors, which lie on the hyperplanes given by Equation 2.16, are used to
build the model. SVM can be employed for multiclass classification.
When the data is non-linearly separable in the given feature space as illustrated
in Figure 2.4(b), kernel trick can be used to transform the data into a higher dimensional
space so that new the data points are linearly separable in the new feature space. Non-
linear kernel function is substituted for the dot product between θ and the data point x; it
measures the similarity of each data point (x) in the original space to all landmark points
(`) in the new feature space and assigns the instance to the closest landmark. There are
many types of kernel functions such as Polynomial, Gaussian, and Hyperbolic Tangent.
In this work, Gaussian Radial Basis kernel function is used which is defined as:
k(xi, `j) = exp(−||xi − `j ||
2
2σ2
) (2.17)
Libsvm package [11] is used for the matlab implementation of SVM.
2.5.3 Random Forest (RF)
Random Forest (RF) is an ensemble classifier combining Bootstrap aggregation (bag-
ging), random feature selection, and decision trees. RF grows many classification trees
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Figure 2.7: Classification trees grown by Random Forest. At each split node, shown in yellow, randomly
n N features are selected and the node is split into two classes. Leaf nodes or terminal nodes, shown
in red/green, are the nodes which cannot be split further indicating that the tree is fully grown. K such trees
are grown and stored as learned model.
[8]. Given a training data X ∈ RMxN , the following steps are involved in growing a
classification tree:
• A bootstrap sample, XB ∈ RMxN , is generated from the given training data, using
sampling with replacement method, and is used as training data to grow the tree.
• A subset of n  N , features is selected at random at each node of the tree.
The node is split based on the best split of these n features. The size n remains
constant throughout the forest generation.
• Each tree is grown fully, without pruning.
K classification trees are grown as shown in Figure 2.7, where K can be any
value; the default value used is 500. An unlabeled instance is passed down to all the
decision trees in the forest and each tree assigns the new instance to one of the class-
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es. This is called voting; the new instance is assigned to the class which gets majority
votes. RF is one of the most accurate learning algorithms. It can efficiently handle
high-dimensional (upto a couple of thousand features) and large scale datasets. It can
effectively estimate missing values, balance error in unbalanced dataset, and can be
extended to unlabeled data. However, unlike decision tree, the classifications made by
RF are difficult to comprehend. The problem of overfitting is observed when the data is
noisy. The matlab implementation of random forest algorithm is obtained from [24].
2.6 Performance Measures
This section discusses the various performance metrics used to evaluate the efficacy
of the learned model. Confusion matrix for binary classification problems is shown in
Table 2.1.
Table 2.1: Confusion Matrix
Test Outcome Condition
Positive True Positive(TP) False Positive(FP)
Negative False Negative(FN) True Negative(TN)
where TP refers to number of samples correctly identified as positive, FP refers
to number of samples incorrectly identified as positive, TN refers to number of sam-
ples correctly identified as negative, and FN refers to number of samples incorrectly
identified as negative.
False Positive Rate (FPR) is the probability of falsely rejecting null hypothesis
when it is true. It is also known as Type I error and is defined as:
FPR =
FP
FP + TN
(2.18)
Accuracy is defined as percentage of true results and is given by the formula:
Accuracy =
TP + TN
TP + FN + FP + TN
X 100 (2.19)
Sensitivity, also known as recall rate or True Positive Rate (TPR), is the ratio of people
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Figure 2.8: Receiver-Operating Characteristic (ROC) space. The area under the ROC
curve is known as Area Under the Curve (AUC).
who are correctly identified as positive. It is computed using the formula:
Sensitivity =
TP
TP + FN
(2.20)
Specificity, is the ratio of people who are correctly identified as belonging to negative
class. It is know known as 1 minus False Positive Rate(FPR). It is computed using the
formula:
Specificity =
TN
TN + FP
(2.21)
Area under the curve (AUC) is defined as the area under Receiver-Operating Charac-
teristic (ROC) curve. A ROC curve is created by plotting TPR as a function of FPR as
illustrated in Figure 2.8. The diagonal line, also known as random guess line, defines
the benchmark for classification results. Points above the diagonal are good, those on
the diagonal are random guesses, and points below the diagonal are sub-optimal.
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CHAPTER 3
EXPERIMENTS
This chapter gives a detailed account of experiments performed and results obtained.
The following feature selection algorithms were analyzed in this study: Student′s t-test
(T-test), Relief-F, FisherKernel, GiniIndex, Information Gain (InfoGain), Kruskal-Wallis,
Chi-Square, Minimum Redundancy Maximum Relevance (mRMR), and Sparse Logis-
tic Regression with Stability Selection (SSLogisticR). Random Forest (RF) and Support
Vector Machines (SVM) classifiers were used to analyze the efficacy of the feature se-
lection algorithms.
3.1 Dataset: Alzheimer′s Disease Neuroimaging Initiative (ADNI)
In the ADNI longitudinal study, blood plasma proteins obtained from an RBM panel (RB-
M), Magnetic Resonance Imaging (MRI), and Psychometric assessment scores (META)
biomarkers1 were studied at baseline. Table 3.1 lists the number of subjects in each
disease category. NL refers to control (healthy) subjects, MCI refers to patients with
Mild Cognitive Impairment, and AD are patients identified with the debilitating disease.
MCI subjects are further classified as MCI-NC and MCI-C based on their disease s-
tatus in the longitudinal study. MCI non-converters (MCI-NC) are those MCI subjects
which remain at MCI status and MCI converters (MCI-C) are those MCI subjects who
subsequently progress to AD.
Table 3.1: ADNI Baseline Data Details
Features Feature # NL MCI-NC MCI-C AD Total
RBM 147 58 233 163 112 566
MRI 305 191 177 142 138 648
META 52 218 220 153 171 762
RBM+MRI 452 48 176 142 83 449
RBM+META 199 55 219 153 103 530
MRI+META 357 182 166 133 124 605
RBM+MRI+META 504 45 165 133 78 421
1Refer Appendix A for complete list of features.
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In ADNI proteomics Study, 95 plasma protein features were used at baseline.
There are 54 control, 218 MCI-NC, 162 MCI-C, and 111 AD subjects. This study intends
to develop an algorithm on ADNI dataset which can be successfully applied across other
plasma protein based datasets such as AIBL.
Samples with missing values were discarded from the study and the data ma-
trix was normalized using Equation 2.2 and was partitioned into 10-datasets. Feature
selection algorithms were used to rank features according to their significance. RF and
SVM were used to build learning models using top 1,2,3,...,50 features for each FS al-
gorithm. The learned model was tested on test set and classification measures were
analyzed. The results reported are averaged over 10-datasets. The graphs are drawn
for each performance metric as a function of number of features. The key results have
been included in this chapter.
3.2 ADNI RBM, MRI, and META : MCI-NC vs MCI-C
In this experiment, the task was to identify signatures for predicting MCI-NC (negative
class, 165 members) from MCI-C (positive class, 133 members) subjects. Subject-
s which have non-missing values for RBM, MRI, and META biomarkers and belong to
either MCI-NC or MCI-C category were used. The dataset was partitioned into 10 cross-
folds (subsets) such that each fold was approximately balanced with respect to the two
classes. One fold was used for testing and rest of the 9 folds were used for training,
creating 10 train-test cross validation sets. Area Under the Curve (AUC) was computed
using True Positive Rate (TPR) and False Positive Rate (FPR) for all samples. Seven
experiments were designed for RBM, MRI, META and their valid combinations, each
using same set of samples (a total of 298 subjects), with different set of features.
3.2.1 Results
Protein biomarkers (RBM) gave a maximum of 59.7% classification accuracy for RF and
60.5% for SVM. T-test, Relief-F, FisherKernel, GiniIndex, and SSLogisticR performed
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Figure 3.1: MCI-NC vs MCI-C Classification using RBM features & RF Classifier.
the best. Relief-F gave 59% accuracy using just one feature. As number of features
were increased, its accuracy fluctuated and dropped. It gave comparatively low sensi-
tivity and the same was observed for GiniIndex. The other three FS algorithms: T-test,
FisherKernel, and SSLogisticR showed slow but steady progress with, comparatively,
good AUC (≈0.6). T-test and FisherKernel showed the same performance. Figures 3.1
and 3.2 show the performance measures for all algorithms. Table 3.2 lists the top 20
features selected by the top feature selection algorithms.
Figure 3.3 demonstrates that 6 out of the 10 analytes obtained by SSLogisticR
were also identified by Daniel et al. [25] in a similar study. Many of these features have
been researched directly or indirectly in context of AD. The unique features identified by
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Figure 3.2: MCI-NC vs MCI-C Classification using RBM features & SVM Classifier.
SSLogisticR in this research were extensively studied to evaluate their relevance and
role in pathogenesis of AD. B Lymphocyte Chemoattractant (BLC) protein is encoded by
CXCL13 gene in humans. It is linked to Neuroborreliosis, a disorder of central nervous
system caused by Lyme infection, which has symptoms similar to AD. Interleukin-6
Receptor (IL_6r), a protein complex, is shown to bind with T-lymphocyte in patients with
dementia similar to AD [7]. Betacellulin (BTC) has been shown to promote brain cell
regeneration in mice [18]. Heparin-Binding EGF-Like Growth factor (HB-EGF) has been
shown to interact with BAG1 protein produced by BAG gene which has been implicated
in age-related neurodegenerative diseases.
Integrating RBM and MRI biomarkers increased the prediction accuracy of the
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Figure 3.3: MCI-NC vs MCI-C: Comparing top 10 RBM Biomarkers identified by T-Test,
SSLogisticR, and Daniel et al. [25]
Table 3.2: Top 20 RBM Features
T-Test Relief-F GiniIndex SSLogisticR
Apo_E Apo_C_III CD40_L Cortisol
BTC CD40_L HBEGF SAP
Cortisol HBEGF PARC BTC
CRP AACT Apo_C_III Apo_E
MIP_3alpha Cortisol BTC MIP_3alpha
PAP MIP_1alpha FABP PARC
SAP EGF IL_16 PAP
HBEGF IL_6r LH BLC
PARC ILGFBP MIP_3alpha HBEGF
SOD_1 PDGF_BB Apo_A_II IL_6r
CD40_L PARC AACT FABP
IL_6r Apo_E ILGFBP CRP
MMP_2 SAP MIP_1alpha Nr_CAM
Nr_CAM TNFAILR PAP PYY
PDGF_BB VKDPS AAT Apo_C_III
Apo_C_III ANG_2 Cortisol Apo_C_II
IL_8 CRP CRP TNFAILR
Apo_C_II Insulin Sortilin CD40_L
FABP TBG ANG_2 THP
IL_16 BTC Apo_E TECK
algorithm by 12%, resulting in the maximum test accuracy of 72.8%. RF overshadowed
SVM in this case as shown in Figures 3.4 and 3.5. With the exception of Kruskal-
Wallis, all algorithms performed equally well. SSLogisticR was the only algorithm which
showed smooth accuracy curve as number of features were increased. Table 3.3 list-
s the top 20 features selected by the top algorithms. Many studies have shown the
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Figure 3.4: MCI-NC vs MCI-C Classification using RBM+MRI features & RF Classifier.
potential of MCI biomarkers in predicting pre-clinical AD. Hence, it was not surprising
that the top features, by univariate feature selection algorithms, were dominated by MCI
biomarkers. Sparse Logistic Regression (SSLogisticR) was able to capture the correla-
tion between RBM and MCI features.
Combining RBM and META biomarkers did not show any significant improve-
ment, reporting an accuracy increase of only 4%. Figures 3.6 and 3.7 illustrate the
performance measures of different feature selection algorithms using RF and SVM re-
spectively. MRI and META features individually gave 60% to 70% accuracy. However,
no significant improvement was observed when these features were combined.
Integrating RBM, MRI, and META biomarkers resulted in a significant improve-
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Figure 3.5: MCI-NC vs MCI-C Classification using RBM+MRI features & SVM Classifier.
ment over RBM-only accuracy (17% increase), with comparable performance from RF
and SVM. Except Kruskal-Wallis, all algorithms performed equally well. The accuracy
curve of most algorithms was smooth compared to previous feature combinations. This
approach yielded an average AUC of 0.73, a sensitivity of 0.65 a specificity of 0.76.
Table 3.4 lists the top 20 features selected by top algorithms. The features selected by
SSLogisticR consisted of a balanced mixture of all three biomarkers thereby resulting
in better performance. Figure 3.10 demonstrates the efficiency of integrative methods
by comparing their accuracy obtained using RF for top 10 features selected by SS-
LogisticR. Performances of RF and SVM for different feature selection algorithms are
illustrated in Figures 3.8 and 3.9 respectively.
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Table 3.3: Top 20 RBM and MRI Features
T-Test Relief-F
Volume (WM Parcellation) of LeftAmygdala Volume (WM Parcellation) of LeftAmygdala
Volume (Cortical Parcellation) of LeftEntorhinal Volume (Cortical Parcellation) of LeftEntorhinal
Volume (WM Parcellation) of LeftHippocampus Cortical Thickness Avg of LeftEntorhinal
Cortical Thickness Avg of LeftIsthmusCingulate Cortical Thickness Avg of LeftFusiform
Cortical Thickness Avg of LeftRostralMiddle-
Frontal
Volume (WM Parcellation) of LeftHippocampus
Cortical Thickness Avg of LeftTemporalPole Cortical Thickness Avg of LeftPrecuneus
Volume (WM Parcellation) of RightAmygdala Cortical Thickness Avg of LeftTemporalPole
Cortical Thickness Avg of RightEntorhinal Volume (WM Parcellation) of RightAmygdala
Volume (WM Parcellation) of RightHippocampus Cortical Thickness Avg of RightEntorhinal
Cortical Thickness Avg of RightIsthmusCingulate Volume (WM Parcellation) of RightHippocampus
Cortical Thickness Avg of RightMiddleTemporal Cortical Thickness Avg of RightMiddleTemporal
Cortical Thickness Avg of RightInsula Cortical Thickness Avg of LeftIsthmusCingulate
Volume (Cortical Parcellation) of RightInferior-
Parietal
Cortical Thickness Avg of LeftMiddleTemporal
Cortical Thickness Avg of RightPrecuneus Cortical Thickness Avg of RightInferiorParietal
Cortical Thickness STDV of RightPrecuneus Cortical Thickness Avg of RightIsthmusCingulate
Cortical Thickness Avg of LeftEntorhinal Volume (Cortical Parcellation) of RightMid-
dleTemporal
Cortical Thickness Avg of LeftMiddleTemporal Cortical Thickness Avg of LeftInferiorParietal
Cortical Thickness Avg of LeftInsula Cortical Thickness Avg of LeftInferiorTemporal
Cortical Thickness Avg of RightInferiorParietal Cortical Thickness Avg of LeftRostralMiddle-
Frontal
Cortical Thickness Avg of RightInferiorTemporal Volume (Cortical Parcellation) of LeftInferiorTem-
poral
GiniIndex SSLogisticR
Volume (WM Parcellation) of LeftAmygdala Volume (WM Parcellation) of LeftHippocampus
Volume (Cortical Parcellation) of LeftEntorhinal Volume (Cortical Parcellation) of LeftEntorhinal
Cortical Thickness Avg of LeftEntorhinal Cortical Thickness STDV of RightPrecuneus
Cortical Thickness Avg of LeftFusiform PARC
Volume (WM Parcellation) of LeftHippocampus Cortisol
Cortical Thickness Avg of LeftIsthmusCingulate PYY
Cortical Thickness Avg of LeftPericalcarine HBEGF
Cortical Thickness Avg of LeftTemporalPole Cortical Thickness STDV of LeftBankssts
Volume (WM Parcellation) of RightAmygdala Volume (Cortical Parcellation) of LeftTempo-
ralPole
Cortical Thickness Avg of RightEntorhinal Cortical Thickness STDV of LeftEntorhinal
Volume (WM Parcellation) of RightHippocampus Cortical Thickness STDV of LeftPostcentral
Cortical Thickness Avg of RightMiddleTemporal Cortical Thickness Avg of LeftIsthmusCingulate
Volume (Cortical Parcellation) of LeftInferiorTem-
poral
CRP
Cortical Thickness Avg of LeftPrecuneus PLGF
Volume (Cortical Parcellation) of LeftInferiorPari-
etal
IL_16
Volume (Cortical Parcellation) of RightMid-
dleTemporal
Insulin
Cortical Thickness Avg of RightSuperiorTemporal Nr_CAM
Cortical Thickness Avg of RightIsthmusCingulate Cortical Thickness Avg of RightEntorhinal
Cortical Thickness STDV of RightPrecuneus MIP_3alpha
Cortical Thickness Avg of RightInsula IL_6r
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Figure 3.6: MCI-NC vs MCI-C Classification using RBM+META features & RF Classifier.
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Figure 3.7: MCI-NC vs MCI-C Classification using RBM+META features & SVM Classi-
fier.
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Table 3.4: Top 20 RBM, MRI,& META Features
T-Test Relief-F
Volume (WM Parcellation) of LeftAmygdala Volume (Cortical Parcellation) of LeftEntorhinal
Volume (Cortical Parcellation) of LeftEntorhinal Volume (WM Parcellation) of LeftHippocampus
Volume (WM Parcellation) of LeftHippocampus Cortical Thickness Avg of LeftTemporalPole
Cortical Thickness Avg of RightEntorhinal Volume (WM Parcellation) of RightAmygdala
Volume (WM Parcellation) of RightHippocampus Cortical Thickness Avg of RightEntorhinal
Cortical Thickness Avg of RightMiddleTemporal Volume (WM Parcellation) of RightHippocampus
LDELTOTAL Cortical Thickness Avg of RightMiddleTemporal
ADAS_sub1 LDELTOTAL
ADAS_sub4 ADAS_sub1
ADAS_sub7 ADAS_sub4
FAQ ADAS_sub7
Cortical Thickness Avg of LeftIsthmusCingulate FAQ
Cortical Thickness Avg of LeftRostralMiddle-
Frontal
APOE
Volume (WM Parcellation) of RightAmygdala Volume (WM Parcellation) of LeftAmygdala
Volume (Cortical Parcellation) of RightInferior-
Parietal
Cortical Thickness Avg of LeftEntorhinal
Cortical Thickness Avg of LeftTemporalPole Cortical Thickness Avg of LeftFusiform
Cortical Thickness Avg of RightIsthmusCingulate Cortical Thickness Avg of LeftPrecuneus
Cortical Thickness Avg of RightInsula Cortical Thickness Avg of LeftIsthmusCingulate
Cortical Thickness Avg of LeftEntorhinal Cortical Thickness Avg of RightIsthmusCingulate
Cortical Thickness Avg of RightInferiorTemporal CDR
GiniIndex SSLogisticR
Volume (WM Parcellation) of LeftAmygdala FAQ
Volume (Cortical Parcellation) of LeftEntorhinal ADAS_sub4
Cortical Thickness Avg of LeftEntorhinal LDELTOTAL
Cortical Thickness Avg of LeftFusiform ADAS_sub1
Volume (WM Parcellation) of LeftHippocampus ADAS_sub7
Cortical Thickness Avg of LeftPericalcarine CRP
Cortical Thickness Avg of LeftTemporalPole Cortical Thickness STDV of RightPrecuneus
Volume (WM Parcellation) of RightAmygdala Volume (Cortical Parcellation) of LeftTempo-
ralPole
Cortical Thickness Avg of RightEntorhinal PARC
Volume (WM Parcellation) of RightHippocampus Volume (WM Parcellation) of LeftHippocampus
Cortical Thickness Avg of RightMiddleTemporal Volume (Cortical Parcellation) of LeftEntorhinal
LDELTOTAL Volume (WM Parcellation) of RightCerebellum-
Cortex
ADAS_sub1 Cortical Thickness STDV of LeftCuneus
ADAS_sub4 PYY
FAQ Nr_CAM
Volume (Cortical Parcellation) of LeftInferiorPari-
etal
SAP
Volume (Cortical Parcellation) of RightMid-
dleTemporal
IL_16
Volume (Cortical Parcellation) of LeftInferiorTem-
poral
APOE
Cortical Thickness Avg of LeftPrecuneus NPI
Cortical Thickness Avg of LeftIsthmusCingulate Cortisol
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Figure 3.8: MCI-NC vs MCI-C Classification using RBM+MRI+META features & RF
Classifier.
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Figure 3.9: MCI-NC vs MCI-C Classification using RBM+MRI+META features & SVM
Classifier.
Figure 3.10: MCI-NC vs MCI-C: Comparison of RF Accuracy obtained for top 10
biomarkers selected by SSLogisticR using various Integrative Approaches.
42
3.3 ADNI Proteomics: NL vs AD
This is an NL vs AD classification experiment with 54 NL (negative class) and 111 AD
(positive class) subjects. Since this is an unbalanced data, over and under sampling
approaches are evaluated. The given unbalanced dataset is randomly partitioned into
train-test set in 9:1 ratio. For each sampling method, 10 such datasets are generated.
Table 3.5 gives the number of training and testing samples used in various sampling
methods.
Table 3.5: NL vs AD : Dataset Details
No Sampling Under Sampling Over Sampling
Target Sample # Train Test Train Test Train Test
AD(positive) 111 99 12 48 12 99 12
NL(negative) 54 48 6 48 6 96 6
Total 165 147 18 96 18 195 18
3.3.1 Results
Table 3.6: Top 20 features for NL vs AD
T-test Relief-F GiniIndex SSLogisticR
log10(ApoE) log10(ApoE) log10(ApoE) log10(ApoE)
log10(IGM) log10(IGM) log10(BTC) log10(SGOT)
log10(PAPPA) log10(MIP1alpha) log10(PAPPA) log10(IL16)
log10(SGOT) log10(PAPPA) log10(SGOT) log10(IGM)
log10(HBEGF) log10(SGOT) log10(IGM) log10(A2Micro)
log10(TIMMP1) log10(TNC) log10(MIP1alpha) log10(PAPPA)
log10(TNC) log10(A2Micro) log10(A2Micro) log10(ApoB)
log10(A2Micro) log10(TIMMP1) log10(C3) log10(TNC)
log10(C3) log10(C3) log10(HGF) log10(HBEGF)
log10(B2M) log10(BTC) log10(PPP) log10(MIP1alpha)
log10(IL16) log10(HBEGF) log10(TIMMP1) log10(PPP)
log10(MIP1alpha) log10(IL16) log10(TNC) log10(CEA)
log10(VCAM) log10(PPP) log10(HBEGF) log10(C3)
log10(PPP) log10(VCAM) log10(IL16) log10(ATEN)
log10(VEGF) log10(ACE) log10(ApoH) log10(ADP)
log10(Apo_C3) log10(Apo_C3) log10(Apo_C3) log10(CORTISOL)
log10(ApoB) log10(ApoB) log10(CRP) log10(CRP)
log10(ApoH) log10(VEGF) log10(ACE) log10(VEGF)
log10(BTC) log10(ADP) log10(ApoB) log10(HGF)
log10(TBG) log10(ATEN) log10(CORTISOL) log10(BTC)
Results for no sampling and over-sampling approaches were comparable. Over-
sampling performed better in few cases. High sensitivity (SN) of 0.95 was observed in
both of these sampling approaches. Specificity (SP) was observed between 0.61 and
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Figure 3.11: NL vs AD Classification using Under-Sampling features & RF Classifier.
0.67 while AUC was in the range of 0.75. Test Accuracy (TA) was between 72% and
83%, but standard deviation (STDV) was very high. In light of these factors, these t-
wo techniques did not give satisfactory results. SSLogisticR showed good results in
the case of over-sampling using RF (TA-84.44%, STDV-6.83, AUC-0.82, SN-0.94, SP-
0.65). RF performed better than SVM.
Under-sampling accuracy was ≈79.8%, showing high standard deviation, but
comparable sensitivity and specificity (less than 0.75). Average AUC observed was
0.78. Reilef-F showed a smooth increase in performance with increasing number of
features, although performance fluctuations were seen. GiniIndex did not perform well
for very less number of features, but slowly gained 80% accuracy for top 45 features.
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Figure 3.12: NL vs AD Classification using Under-Sampling features & SVM Classifier.
Other algorithms fluctuated a lot and showed average performance. Performance mea-
sures of various feature selection algorithms using RF and SVM classifiers are shown
in Figures 3.11 and 3.12 respectively. Table 3.6 lists the top 20 features from the top
algorithms.
Daniel et al. [25] used all RBM features shown in table 3.1 and 54 samples
from each class to find protein signatures for predicting AD subjects. They obtained
21-protein signature; 11 of these were studied in this experiment. A total of 9 analytes
matched the biomarkers obtained by SSLogisticR as shown in figure 3.13. The rele-
vance of features not previously identified was analyzed in detail. Several researcher-
s have identified significant difference in Cortisol levels, a stress related hormone, in
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Figure 3.13: NL vs AD: Comparing top 10 RBM Biomarkers obtained using Under-
sampling approach by T-Test, SSLogisticR, and Daniel et al. [25]
healthy, MCI-NC, MCI-C, and AD patients [33][5]. Adiponectin (ADP) is a protein hor-
mone found in body fat and has been linked to dementia [47]. Une et al. [46] studied the
ADP levels in plasma and CSF in NL, MCI, and AD subjects. C Reactive Protein (CRP)
levels rise in response to inflammation. Wood et al. [48] found increased levels of CRP
in Alzheimer′s cortex. Macrophage inflammatory Protein 1 alpha (MIP_1alpha or CCL3)
plays a crucial role in immune response and has a proinflammatory effect. Tripathy et
al. [43] found increased levels of MIP_1alpha in Alzheimer′s Vessels. Carcinoembry-
onic antigen (CEA) is a glycoprotein involved in cell adhesion and mainly studied in
context of cancerous tumors. Licastro et al. [30] studied the role of environmental
factors in pathogenesis of AD and found CEA to be a key modulator in neuronal loss,
inflammation, and amyloid deposition. Angiotensinogen (ATEN or AGT), also known as
renin substrate, is an α-2 globulin and its role in neurodegenerative disorders has been
studied by Savaskan et al. [41]. Hepatocyte growth factor (HGF) regulates cell growth,
cell motility, and morphogenesis. Tsuboi et al. [44] found that white matter damage in
AD brain is correlated to CSF HGF levels. Tenascin C (TNC) has anti cell adhesive
properties and its role in neuroprotection has been extensively studied by Alzheimer
and Werner [4]. Apolipoprotein B (Apo_B) has been studied in context of heart disease.
Caramelli et al. [10] noted high serum concentration of Apo_B in AD subjects.
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3.4 ADNI Proteomics: NL vs MCI
In this experiment, both MCI-NC and MCI-C samples were used in positive class, NL
being the negative class. The dataset setup was similar to Section 3.3. Table 3.7 gives
the break-up of training and testing data used in various sampling methods:
Table 3.7: NL vs MCI : Dataset Details
No Sampling Under Sampling Over Sampling
Target Sample # Train Test Train Test Train Test
MCI_All(positive) 380 342 38 48 38 342 38
NL(negative) 54 48 6 48 6 336 6
Total 165 147 18 96 18 195 18
3.4.1 Results
When no sampling methods were used, test accuracy was as high as 95%. AUC was
very low and results showed very high sensitivity, close to 0.98, and low specificity in-
dicative of the dominance of positive samples. None of the feature selection algorithms
were able to find good set of features in this case. SSLogisticR proved to be more stable
than others. Over-sampling method initially looked promising, but after 3 to 5 features
it started depicting high sensitivity and low specificity. AUC statistics were better in
over-sampling than in no sampling.
Under-sampling gave the best results. Almost all algorithms showed greater
than 74% accuracy using the top four biomarkers. The overall maximum test accuracy
was 83%; other performance statistics were also good. SSLogisticR was the best per-
forming algorithm giving the highest accuracy of 84.5%. The algorithms ordered by their
performance are as follows: SSLogisticR, GiniIndex, T-Test, Relief-F, FisherKernel, In-
foGain, ChiSquare, KruskalWallis, mRMR. InfoGain was better than GiniIndex initially,
but it fluctuated and showed no increase in performance as the number of features were
increased. RF performed better than SVM. Table 3.8 shows the top 20 features select-
ed by the top algorithms for under-sampling. Performance measures of different feature
selection algorithms using RF and SVM classifiers are illustrated in Figures 3.15 and
3.16 respectively. Comparison of different sampling approaches is illustrated in Figure
47
(a) No Sampling (b) Under Sampling
(c) Over Sampling
Figure 3.14: NL vs MCI: Comparison of different sampling approaches using RF perfor-
mance measures for top 10 features identified by SSLogisticR
Table 3.8: Top 20 Features for NL vs MCI
T-test Relief-F GiniIndex SSLogisticR
log10(ApoE) log10(ApoE) log10(ApoE) log10(ApoE)
log10(MIP1alpha) log10(HBEGF) log10(HBEGF) log10(MIP1alpha)
log10(PAPPA) log10(MIP1alpha) log10(MIP1alpha) log10(ApoD)
log10(ANG2) log10(ANG2) log10(ANG2) log10(PARC)
log10(ApoD) log10(FASL) log10(BTC) log10(PAPPA)
log10(FASL) log10(PAPPA) log10(SGOT) log10(ANG2)
log10(FAC7) log10(A2Micro) log10(A2Micro) log10(HBEGF)
log10(HBEGF) log10(ACE) log10(FASL) log10(ACE)
log10(Leptin) log10(IL16) log10(IL16) log10(ATEN)
log10(PARC) log10(Leptin) log10(PPP) log10(FASL)
log10(ACE) log10(SGOT) log10(CRP) log10(IL16)
log10(ATEN) log10(ApoD) log10(HGF) log10(A2Micro)
log10(IL16) log10(BTC) log10(ACE) log10(CgA)
log10(PPP) log10(CRP) log10(ApoD) log10(PPP)
log10(CRP) log10(C3) log10(Leptin) log10(TEST)
log10(IGM) log10(IGM) log10(PAPPA) log10(NrCAM)
log10(IIGFBP) log10(PPP) log10(TNC) log10(CRP)
log10(BMP_6) log10(Apo_C3) log10(ATEN) log10(Leptin)
log10(CgA) log10(ATEN) log10(C3) log10(BTC)
log10(FRTN) log10(BMP_6) log10(FAC7) log10(RESISTIN)
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Figure 3.15: NL vs MCI Classification using Under-Sampling features & RF Classifier.
3.14 for top 10 features obtained by SSLogisticR and classified by RF. Results obtained
using no sampling and over-sampling approaches depict high accuracy and sensitivity
but poor specificity. In comparison, under-sampling technique resulted in reasonable
accuracy in conjunction with good sensitivity and specificity. Similar results have also
been noted in a recent work by Chawla et al. [12].
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Figure 3.16: NL vs MCI Classification using Under-Sampling features & SVM Classifier.
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3.5 ADNI Proteomics: MCI-NC vs MCI-C
In this experiment, MCI-NC samples belong to negative class and MCI-C samples were
used as positive class. The dataset setup is similar to Section 3.3. Table 3.9 gives the
break-up of training and testing data used in various sampling methods.
Table 3.9: MCI-NC vs MCI-C : Dataset Details
No Sampling Under Sampling Over Sampling
Target Sample # Train Test Train Test Train Test
MCI-C(positive) 162 145 17 145 17 195 17
MCI-NC(negative) 218 196 22 145 22 196 22
Total 165 147 18 96 18 195 18
3.5.1 Results
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Figure 3.17: MCI-NC vs MCI-C Classification using Under-Sampling features & RF
Classifier.
51
0 5 10 15 20 25 30 35 40 45 50
46
48
50
52
54
56
58
60
62
Number of Features
Un
de
r S
am
pl
in
g 
SV
M
 A
cc
ur
ac
y
 
 
T−test
Relief−F
FisherKernel
GiniIndex
InfoGain
KruskalWallis
ChiSquare
mRMR
SSLogisticR
(a) Accuracy(%)
0 5 10 15 20 25 30 35 40 45 50
0.48
0.5
0.52
0.54
0.56
0.58
0.6
0.62
0.64
0.66
Number of Features
Un
de
r S
am
pl
in
g 
SV
M
 A
UC
(b) AUC
0 5 10 15 20 25 30 35 40 45 50
0.35
0.4
0.45
0.5
0.55
0.6
0.65
0.7
Number of Features
Un
de
r S
am
pl
in
g 
SV
M
 S
en
sit
ivi
ty
(c) Sensitivity
0 5 10 15 20 25 30 35 40 45 50
0.45
0.5
0.55
0.6
0.65
0.7
0.75
Number of Features
Un
de
r S
am
pl
in
g 
SV
M
 S
pe
cif
ici
ty
(d) Specificity
Figure 3.18: MCI-NC vs MCI-C Classification using Under-Sampling features & SVM
Classifier.
Predicting MCI-NC from MCI-C subjects is a difficult task due to heterogeneity
of MCI-NC category. Effect of large number of negative samples is clearly evident from
the high specificity of 0.82 and low sensitivity of 0.31 when no sampling method is
used. The maximum test accuracy achieved was 61%. AUC and sensitivity were also
very low. Over-sampling reduced the gap between specificity and sensitivity values,
however it did not help improve accuracy. The performance of RF and SVM was similar
in both sampling approaches.
In case of under-sampling, AUC, sensitivity, and specificity, were all between
0.5 and 0.55. None of the algorithms showed a smooth accuracy curve; the accuracy
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Table 3.10: Top 20 features for MCI-NC vs MCI-C
T-test Relief-F GiniIndex
log10(CORTISOL) log10(FSH) log10(CRP)
log10(Apo_C3) log10(THBP) log10(FABP)
log10(ApoE) log10(Apo_C3) log10(Apo_C3)
log10(CRP) log10(ATEN) log10(CgA)
log10(FABP) log10(CORTISOL) log10(IIGFBP)
log10(HGF) log10(CRP) log10(ANG2)
log10(NrCAM) log10(PPP) log10(ApoE)
log10(SAP) log10(CD40_L) log10(FSH)
log10(FSH) log10(CEA) log10(CORTISOL)
log10(IIGFBP) log10(TEST) log10(LPA)
log10(PAP) log10(CA_19_9) log10(MDC)
log10(PARC) log10(CgA) log10(IL18)
log10(HBEGF) log10(EDNA) log10(Insulin)
log10(CgA) log10(Insulin) log10(MIP1alpha)
log10(MMP2) log10(ApoD) log10(PAP)
log10(ANG2) log10(ApoE) log10(SAP)
log10(ATEN) log10(AXL) log10(ATEN)
log10(AXL) log10(EGF) log10(I309)
log10(CA_19_9) log10(IIGFBP) log10(MMP9)
log10(I309) log10(LPA) log10(TEST)
InfoGain KruskalWallis SSLogisticR
log10(A2Micro) log10(ACE) log10(CORTISOL)
log10(ACE) log10(Apo_C3) log10(FABP)
log10(ADP) log10(ATEN) log10(CRP)
log10(AFP) log10(CORTISOL) log10(ApoE)
log10(ANG2) log10(FSH) log10(Apo_C3)
log10(Apo_A1) log10(IIGFBP) log10(SAP)
log10(Apo_C3) log10(ANG2) log10(PAP)
log10(ApoB) log10(Apo_A1) log10(NrCAM)
log10(ApoD) log10(PPP) log10(CgA)
log10(ApoE) log10(Insulin) log10(IIGFBP)
log10(ApoH) log10(PAI1) log10(HBEGF)
log10(ATEN) log10(SHBG) log10(HGF)
log10(AXL) log10(GH) log10(LPA)
log10(B2M) log10(LH) log10(I309)
log10(BDNF) log10(AFP) log10(FSH)
log10(BLC) log10(MMIF) log10(MMP2)
log10(BMP_6) log10(Myoglobin) log10(AXL)
log10(BTC) log10(IGA) log10(IGA)
log10(C3) log10(ApoB) log10(FAC7)
log10(CA_19_9) log10(CD40) log10(CA_19_9)
dropped after 25 features in all cases. Reilef-F and GiniIndex gave 58% and 57% ac-
curacy respectively for the topmost feature. However, as the number of features were
increased, accuracy fluctuated and dropped. Performance of T-Test, FisherKernel, and
SSLogisticR was comparable. Kruskal-Wallis gave the highest accuracy of 61.3%, but
the accuracy dropped with increasing features. InfoGain, ChiSquare, and mRMR per-
formed better than the aforementioned algorithms. The accuracy obtained was 59%
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with increased stability compared to other techniques. InfoGain was the most promis-
ing amongst the three. Performance measures of various feature selection algorithms
using RF and SVM classifiers are shown in Figures 3.17 and 3.18 respectively. Table
3.10 shows the top performing algorithms with top features.
3.6 ADNI Proteomics: NL vs MCI-NC
The purpose of this experiment was to identify potent biomarkers for predicting NL (neg-
ative class) from MCI-NC (positive class) subjects. The dataset setup is similar to Sec-
tion 3.3. Table 3.11 gives the break-up of training and testing data used in various
sampling methods:
Table 3.11: NL vs MCI-NC : Dataset Details
No Sampling Under Sampling Over Sampling
Target Sample # Train Test Train Test Train Test
MCI-NC(positive) 218 196 22 48 22 196 22
NL(negative) 54 48 6 48 6 192 6
Total 165 147 18 96 18 195 18
3.6.1 Results
Table 3.12: Top 20 Features for NL vs MCI-NC
Relief-F GiniIndex InfoGain mRMR SSLogisticR
log10(HBEGF) log10(HBEGF) log10(ACE) log10(ApoH) log10(MIP1alpha)
log10(MIP1alpha) log10(MIP1alpha) log10(ADP) log10(ATEN) log10(HBEGF)
log10(ApoD) log10(BTC) log10(AFP) log10(AXL) log10(ApoD)
log10(PAPPA) log10(SGOT) log10(ANG2) log10(B2M) log10(ATEN)
log10(SGOT) log10(ANG2) log10(Apo_A1) log10(BDNF) log10(PAPPA)
log10(ATEN) log10(ApoD) log10(Apo_C3) log10(BLC) log10(ACE)
log10(ANG2) log10(HGF) log10(ApoB) log10(BMP_6) log10(PARC)
log10(FASL) log10(ATEN) log10(ApoD) log10(BTC) log10(ANG2)
log10(HGF) log10(EGFR) log10(ApoE) log10(C3) log10(IL16)
log10(IGM) log10(IGM) log10(ApoH) log10(CA_19_9) log10(IGM)
log10(IL16) log10(ACE) log10(ATEN) log10(CD40) log10(A2Micro)
log10(A2Micro) log10(FASL) log10(AXL) log10(HBEGF) log10(TSH)
log10(ACE) log10(Leptin) log10(HBEGF) log10(MIP1alpha) log10(FASL)
log10(Apo_C3) log10(PAPPA) log10(MIP1alpha) log10(ApoD) log10(CgA)
log10(BTC) log10(PPP) log10(BTC) log10(ApoB) log10(RESISTIN)
log10(MMIF) log10(A2Micro) log10(SGOT) log10(CD40_L) log10(CORTISOL)
log10(RESISTIN) log10(Apo_C3) log10(B2M) log10(SGOT) log10(Leptin)
log10(TEST) log10(CRP) log10(EGFR) log10(Apo_A1) log10(SGOT)
log10(CRP) log10(FAC7) log10(HGF) log10(Apo_C3) log10(MMIF)
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Figure 3.19: NL vs MCI-NC Classification using Under-Sampling features & RF Classi-
fier.
Without using any sampling, RF gave unsatisfactory results with an average
sensitivity of 1.0 and a specificity of 0.1. SVM performed better than RF with an aver-
age sensitivity of 0.93 and a specificity of 0.45. SSLogisticR, using SVM, showed the
best and stable results with 87% accuracy using the top 25 features. Over-sampling
approach did not show any improvement; working well for couple of topmost features,
but as the number of features increased, sensitivity started increasing, decreasing AUC
and specificity. The performance of SVM was better than RF.
Under-sampling approach helped improve the performance measure giving AUC,
sensitivity, and specificity between 0.7 and 0.8. The best performing algorithm was SS-
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Figure 3.20: NL vs MCI-NC Classification using Under-Sampling features & SVM Clas-
sifier.
LogisticR followed by Relief-F, GiniIndex, mRMR, and InfoGain. ChiSquare was com-
parable to InfoGain; Kruskal-Wallis did not perform well; T-Test and FisherKernel were
average in performance. In RF, the maximum accuracy observed was 77%; whereas
SVM reported the highest accuracy of 80.35%. Table 3.12 shows the list of top features
obtained using the top algorithms. Performance measures of different feature selec-
tion algorithms using RF and SVM classifiers are illustrated in Figures 3.19 and 3.20
respectively.
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CHAPTER 4
CONCLUSIONS AND FUTURE WORK
4.1 Conclusions
Alzheimer′s Disease (AD) is a neuro-degenerative disease affecting the elderly. Aver-
age life expectancy after diagnosis of the disease is seven years. Most of the treatments
aim to provide relief from the symptoms of the disease. It is imperative to diagnose the
disease so that future treatments could then target the disease in its earliest stages, be-
fore irreversible brain damage or mental decline has occurred. Several genetic, imaging
and biochemical markers are being explored to monitor progression of AD and explore
treatment and detection options. Identification of blood based biomarkers would offer a
quick and effective way to diagnose and monitor the disease. This novel study analyzes
Alzheimer′s Disease Neuroimaging Initiative (ADNI) data using numerous integrative
approaches to find the most potent biomarkers for early diagnosis of AD. This work d-
iffers from previous efforts in its use of a multitude of feature selection (FS) Algorithms
for prediction and prognosis of AD.
The FS Algorithms studied in this thesis are unpaired Student′s t-test (T-Test),
Relief-F with 10 nearest neighbors, Information Gain, GiniIndex, Chi-Square, FisherK-
ernel, Kruskal-Wallis, mRMR with Mutual Information as the distance measure between
the class and the feature, and Logistic regression with `1-norm regularization and Sta-
bility Selection (SSLogisticR). Two metrics have been used to gauge the performance
of feature selection algorithms: the relevance of biomarkers with respect to the prior art
and the predictive power of the algorithm using Random Forest (RF) and Support Vector
Machines (SVM) classifiers. Samples with missing values and outliers were discarded
from the study. Various sampling approaches were analyzed to handle unbalanced
data.
Sparse Logistic Regression algorithm proved to be most effective. The perfor-
mance of the algorithm increased with the increasing number of features and it was
observed to handle unbalanced data elegantly compared to other algorithms. Relief-F
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performed well in most cases giving good results with a small subset of features. T-Test
and FisherKernel were similar in performance and were stable compared to Reilef-
F. However, both of these techniques required a larger feature subset to achieve the
same level of performance as Reilef-F. GiniIndex was comparable to Relief-F. It per-
formed well with smaller subset of features than Relief-F. However these results did
not hold for all prediction tasks. InfoGain and ChiSquare performed equally well. Both
of these methods, designed for categorical or discrete values, did not generalize well
for continuous values. They showed average performance and were not stable with
increasing number of features. Kruskal-Wallis did not show satisfactory performance in
most prediction tasks except in MCI-NC vs MCI-C prediction, where it was one of the
top performing algorithms. Since the algorithm is based on ranking of an observation,
which is a discrete value, it did not perform well on continuous value data. mRMR was
a computationally expensive algorithm and did not give satisfactory results.
While dealing with unbalanced data, the results indicate that no-sampling ap-
proach did not work well due to high bias towards the majority class. Over-sampling
approach also did not give satisfactory results. Under-sampling strategy worked well in
all prediction tasks. The performances of RF and SVM were comparable.
The key finding of this research is that an integrative approach which uses RB-
M, MRI, and META together is more effective than using these factors individually. The
biomarkers identified by this study have been either linked to AD directly or known to
play an important role in other diseases which share the same symptoms as AD.
4.2 Future Work
The main focus of this work was to identify potential protein signatures. This work can
be extended to ascertain the robustness of the derived signatures on longitudinal da-
ta. In future, multivariate approaches utilizing interactions between the samples and
the features can be evaluated for biosignature discovery. The identified proteomics
bio-markers can be ported to other datasets which use the same set of features. An
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integrative approach combining RBM, MRI, and META biomarkers showed promising
results in this work. This approach can be further extended to integrate other biomark-
ers, such CSF and demographic.
The use of tuning parameters to improve the efficacy of feature selection al-
gorithms can be explored. For example, Relief-F can be made more stable by trying
different values of k nearest neighbors on the validation set for each prediction task. RF
and SVM parameters can be tuned by cross validation to achieve higher performance.
Over and under sampling approaches use random duplication and elimination of the da-
ta points respectively. In future, the effect of random addition-deletion can be mitigated
by generating more datasets for each task.
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APPENDIX A
COMPLETE LIST OF ADNI FEATURES
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Table A.1: List of Blood Plasma Protein (RBM) Features
Full Protein Name Short
Name
Full Protein Name Short
Name
Alpha-2-Macroglobulin A2Micro factor VII FAC7
Alpha-1-Antichymotrypsin AACT fASLG Receptor FAS
Alpha-1-Antitrypsin AAT fas Ligand FASL
Angiotensin-Converting enzyme ACE fetuin-A FETA
Adiponectin ADP fibroblast Growth factor 4 FGF4
Alpha-fetoprotein AFP fibrinogen FIBGN
Agouti-Related Protein AGRP ferritin FRTN
Angiopoietin-2 ANG2 follicle-Stimulating Hormone FSH
Apolipoprotein A-I Apo_A1 Growth Hormone GH
Apolipoprotein A-II Apo_A2 Growth-Regulated alpha Protein GRO_alpha
Apolipoprotein A-IV Apo_A4 Glutathione S-Transferase alpha GST_alpha
Apolipoprotein C-I Apo_C1 Haptoglobin HAPG
Apolipoprotein C-III Apo_C3 Heparin-Binding eGf-Like Growth
factor
HBEGF
Apolipoprotein B ApoB Chemokine CC-4 HCC4
Apolipoprotein D ApoD Hepatocyte Growth factor HGF
Apolipoprotein e ApoE T Lymphocyte-Secreted Protein I-
309
I309
Apolipoprotein H ApoH Intercellular Adhesion Molecule 1 ICAM1
Angiotensinogen ATEN Interferon gamma Induced Protein
10
IFGIP10
AXL Receptor Tyrosine kinase AXL Immunoglobulin A IGA
Beta-2-Microglobulin B2M Immunoglobulin e IGE
Brain-Derived neurotrophic factor BDNF Immunoglobulin M IGM
B Lymphocyte Chemoattractant BLC Insulin-like Growth factor-Binding
Protein 2
IIGFBP
Bone Morphogenetic Protein 6 BMP_6 Interleukin-13 IL13
N-terminal prohormone of brain
natriuretic peptide (nT-proBnP)
BNP Interleukin-16 IL16
Betacellulin BTC Interleukin-18 IL18
Complement C3 C3 Interleukin-3 Il3
Cancer Antigen 19-9 CA_19_9 Interleukin-6 Receptor IL6r
Calcitonin CALC Interleukin-8 IL8
CD 40 Antigen CD40 Insulin Insulin
CD40 Ligand CD40_L kidney Injury Molecule-1 KIM1
CD5 Antigen-like CD5L Leptin Leptin
Carcinoembryonic Antigen CEA Luteinizing Hormone LH
Complement factor H CFH Apolipoprotein(a) LPA
Chromogranin-A CgA Monocyte Chemotactic Protein 1 MCP1
Creatine kinase-MB CK_MB Monocyte Chemotactic Protein 2 MCP2
Clusterin CLU Monocyte Chemotactic Protein 3 MCP3
Ciliary neurotrophic factor CNTF Monocyte Chemotactic Protein 4 MCP4
Cortisol CORTISOL Macrophage-Derived Chemokine MDC
C-Peptide CPEP Macrophage Colony-Stimulating
factor 1
MGSF1
C-Reactive Protein CRP Monokine Induced by Gamma In-
terferon
MIGI
Cystatin-C CSTC Macrophage Inflammatory Protein-
1 alpha
MIP1alpha
epithelial-Derived neutrophil-
Activating Protein 78
EDNA Macrophage Inflammatory Protein-
1 beta
MIP1beta
Continued on next page
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epidermal Growth factor EGF Macrophage Inflammatory Protein-
3 alpha
MIP3alpha
epidermal Growth factor Receptor EGFR Macrophage Migration Inhibitory
factor
MMIF
e-Selectin ESEL Matrix Metalloproteinase-1 MMP1
eotaxin-1 ETAX1 Matrix Metalloproteinase-10 MMP10
eotaxin-3 ETAX3 Matrix Metalloproteinase-2 MMP2
fatty Acid-Binding Protein, Heart FABP Matrix Metalloproteinase-7 MMP7
Matrix Metalloproteinase-9 MMP9 Serum Glutamic Oxaloacetic
Transaminase
SGOT
Matrix Metalloproteinase-9, Total MMP9T Sex Hormone-Binding Globulin SHBG
Myeloid Progenitor Inhibitory factor
1
MPIF1 Superoxide Dismutase 1, Soluble SOD1
Myeloperoxidase MPO Sortilin SORTILIN
Myoglobin Myoglobin Thyroxine-Binding Globulin TBG
neutrophil Gelatinase-Associated
Lipocalin
NGAL Thrombospondin-1 TBSP1
neuronal Cell Adhesion Molecule NrCAM Thymus-Expressed Chemokine TECK
Osteopontin OTP Testosterone, Total TEST
Plasminogen Activator Inhibitor 1 PAI1 Trefoil factor 3 TFF3
Prostatic Acid Phosphatase PAP Thrombopoietin THBP
Pregnancy-Associated Plasma
Protein A
PAPPA Tamm-Horsfall urinary Glycopro-
tein
THP
Pulmonary and Activation-
Regulated Chemokine
PARC Tissue Inhibitor of Metallopro-
teinases 1
TIMMP1
Platelet-Derived Growth factor BB PDGFBB Thrombomodulin TM
Proinsulin, Intact PII Tenascin-C TNC
Proinsulin, Total PIT Tumor necrosis factor alpha TNFalpha
Placenta Growth factor PLGF Tnf-Related Apoptosis-Inducing
Ligand Receptor 3
TNFRAILR
Pancreatic Polypeptide PPP Tumor necrosis factor Receptor-
Like 2
TNFRL2
Prolactin PRL Serotransferrin TRANSFERRIN
Peptide YY PYY Thyroid-Stimulating Hormone TSH
Receptor for Advanced Glycosyla-
tion end Products
RAGE Transthyretin TTR
T-Cell-Specific Protein RAnTeS RANTES Vascular Cell Adhesion Molecule-1 VCAM
Resistin RESISTIN Vascular endothelial Growth factor VEGF
Serum Amyloid P-Component SAP Vitronectin VITRN
Stem Cell factor SCF Vitamin k-Dependent Protein S VKDPS
von Willebrand factor vWF
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Table A.2: List of Reduced Proteomics Features
log10(A2Micro) log10(CA_19_9) log10(GH) log10(LH) log10(SAP)
log10(ACE) log10(CD40) log10(GRO_alpha) log10(LPA) log10(SCF)
log10(ADP) log10(CD40_L) log10(HAPG) log10(MCP1) log10(SGOT)
log10(AFP) log10(CEA) log10(HBEGF) log10(MDC) log10(SHBG)
log10(ANG2) log10(CFH) log10(HCC4) log10(MIP1alpha) log10(SOD1)
log10(Apo_A1) log10(CgA) log10(HGF) log10(MIP1beta) log10(SORTILIN)
log10(Apo_C3) log10(CK_MB) log10(I309) log10(MMIF) log10(TBG)
log10(ApoB) log10(CORTISOL) log10(ICAM1) log10(MMP2) log10(TBSP1)
log10(ApoD) log10(CRP) log10(IGA) log10(MMP9) log10(TECK)
log10(ApoE) log10(EDNA) log10(IGE) log10(MPO) log10(TEST)
log10(ApoH) log10(EGF) log10(IGM) log10(Myoglobin) log10(THBP)
log10(ATEN) log10(EGFR) log10(IIGFBP) log10(NrCAM) log10(TIMMP1)
log10(AXL) log10(ETAX1) log10(IL13) log10(PAI1) log10(TNC)
log10(B2M) log10(FABP) log10(IL16) log10(PAP) log10(TNFRAILR)
log10(BDNF) log10(FAC7) log10(IL18) log10(PAPPA) log10(TNFRL2)
log10(BLC) log10(FASL) log10(Il3) log10(PARC) log10(TSH)
log10(BMP_6) log10(FIBGN) log10(IL8) log10(PPP) log10(VCAM)
log10(BTC) log10(FRTN) log10(Insulin) log10(PRL) log10(VEGF)
log10(C3) log10(FSH) log10(Leptin) log10(RESISTIN) log10(vWF)
Table A.3: List of Psychometric Assessment Scores (META Features)
NPI Test RCT4; ALT (SGPT)
ANARTERR Test RCT5; AST (SGOT)
BNTTOTAL Test RCT6; Urea Nitrogen
CATANIMSC Test RCT8; Serum Uric Acid
CATVEGESC Test RCT9; Phosphorus
CLOCKSCOR ADAS_sub1
DIGITSCOR ADAS_sub2
DSPANBAC ADAS_sub3
TRAASCOR ADAS_sub4
TRABSCOR ADAS_sub5
MMSE ADAS_sub6
LDELTOTAL ADAS_sub7
LIMMTOTAL ADAS_sub8
Test RCT1; Total Bilirubin ADAS_sub9
Test RCT11; Serum Glucose ADAS_sub10
Test RCT12; Total Protein ADAS_sub11
Test RCT13; Albumin ADAS_sub12
Test RCT14; Creatine Kinase ADAS_sub13
Test RCT1407; Alkaline Phosphatase Hachinski
Test RCT1408; LDH GDS
Test RCT183; Calcium (EDTA) FAQ
Test RCT19; Triglycerides (GPO) Age
Test RCT20; Cholesterol (High Performance) Gender
Test RCT29; Direct Bilirubin Educat
Test RCT3; GGT CDR
Test RCT392; Creatinine (Rate Blanked) APOE
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Table A.4: List of Magnetic Resonance Imaging (MRI) Features
Volume (WM Parcellation) of RightPallidum Volume (WM Parcellation) of CorpusCallosum-
Central
Volume (Cortical Parcellation) of RightParacentral Volume (Cortical Parcellation) of LeftMiddleTem-
poral
Surface Area of RightParacentral Surface Area of LeftMiddleTemporal
Cortical Thickness Avg of RightParacentral Cortical Thickness Avg of LeftMiddleTemporal
Cortical Thickness STDV of RightParacentral Cortical Thickness STDV of LeftMiddleTemporal
Volume (Cortical Parcellation) of RightParahip-
pocampal
Volume (WM Parcellation) of LeftPallidum
Surface Area of RightParahippocampal Volume (Cortical Parcellation) of LeftParacentral
Cortical Thickness Avg of RightParahippocampal Surface Area of LeftParacentral
Cortical Thickness STDV of RightParahippocam-
pal
Cortical Thickness Avg of LeftParacentral
Volume (Cortical Parcellation) of RightParsOper-
cularis
Cortical Thickness STDV of LeftParacentral
Surface Area of RightParsOpercularis Volume (Cortical Parcellation) of LeftParahip-
pocampal
Cortical Thickness Avg of RightParsOpercularis Surface Area of LeftParahippocampal
Cortical Thickness STDV of RightParsOpercularis Cortical Thickness Avg of LeftParahippocampal
Volume (Cortical Parcellation) of RightParsOr-
bitalis
Cortical Thickness STDV of LeftParahippocampal
Surface Area of RightParsOrbitalis Volume (Cortical Parcellation) of LeftParsOpercu-
laris
Cortical Thickness Avg of RightParsOrbitalis Surface Area of LeftParsOpercularis
Cortical Thickness STDV of RightParsOrbitalis Cortical Thickness Avg of LeftParsOpercularis
Volume (Cortical Parcellation) of RightParsTrian-
gularis
Cortical Thickness STDV of LeftParsOpercularis
Surface Area of RightParsTriangularis Volume (Cortical Parcellation) of LeftParsOrbitalis
Cortical Thickness Avg of RightParsTriangularis Surface Area of LeftParsOrbitalis
Cortical Thickness STDV of RightParsTriangularis Cortical Thickness Avg of LeftParsOrbitalis
Volume (Cortical Parcellation) of RightPerical-
carine
Cortical Thickness STDV of LeftParsOrbitalis
Surface Area of RightPericalcarine Volume (Cortical Parcellation) of LeftParsTriangu-
laris
Cortical Thickness Avg of RightPericalcarine Surface Area of LeftParsTriangularis
Cortical Thickness STDV of RightPericalcarine Cortical Thickness Avg of LeftParsTriangularis
Volume (Cortical Parcellation) of RightPostcentral Cortical Thickness STDV of LeftParsTriangularis
Surface Area of RightPostcentral Volume (Cortical Parcellation) of LeftPericalcarine
Cortical Thickness Avg of RightPostcentral Surface Area of LeftPericalcarine
Cortical Thickness STDV of RightPostcentral Cortical Thickness Avg of LeftPericalcarine
Volume (Cortical Parcellation) of RightPosteri-
orCingulate
Cortical Thickness STDV of LeftPericalcarine
Surface Area of RightPosteriorCingulate Volume (Cortical Parcellation) of LeftPostcentral
Cortical Thickness Avg of RightPosteriorCingulate Surface Area of LeftPostcentral
Cortical Thickness STDV of RightPosteriorCingu-
late
Cortical Thickness Avg of LeftPostcentral
Volume (Cortical Parcellation) of Icv Cortical Thickness STDV of LeftPostcentral
Volume (Cortical Parcellation) of RightPrecentral Volume (WM Parcellation) of CorpusCallosumMi-
dAnterior
Surface Area of RightPrecentral Volume (Cortical Parcellation) of LeftPosteriorCin-
gulate
Cortical Thickness Avg of RightPrecentral Surface Area of LeftPosteriorCingulate
Cortical Thickness STDV of RightPrecentral Cortical Thickness Avg of LeftPosteriorCingulate
Continued on next page
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Volume (Cortical Parcellation) of RightPrecuneus Cortical Thickness STDV of LeftPosteriorCingu-
late
Surface Area of RightPrecuneus Volume (Cortical Parcellation) of LeftPrecentral
Cortical Thickness Avg of RightPrecuneus Surface Area of LeftPrecentral
Cortical Thickness STDV of RightPrecuneus Cortical Thickness Avg of LeftPrecentral
Volume (WM Parcellation) of RightPutamen Cortical Thickness STDV of LeftPrecentral
Volume (Cortical Parcellation) of RightRos-
tralAnteriorCingulate
Volume (Cortical Parcellation) of LeftPrecuneus
Surface Area of RightRostralAnteriorCingulate Surface Area of LeftPrecuneus
Cortical Thickness Avg of RightRostralAnteri-
orCingulate
Cortical Thickness Avg of LeftPrecuneus
Cortical Thickness STDV of RightRostralAnteri-
orCingulate
Cortical Thickness STDV of LeftPrecuneus
Volume (Cortical Parcellation) of RightRostralMid-
dleFrontal
Volume (WM Parcellation) of LeftPutamen
Surface Area of RightRostralMiddleFrontal Volume (Cortical Parcellation) of LeftRostralAnte-
riorCingulate
Cortical Thickness Avg of RightRostralMiddle-
Frontal
Surface Area of LeftRostralAnteriorCingulate
Cortical Thickness STDV of RightRostralMiddle-
Frontal
Cortical Thickness Avg of LeftRostralAnteriorCin-
gulate
Volume (Cortical Parcellation) of RightSuperior-
Frontal
Cortical Thickness STDV of LeftRostralAnteri-
orCingulate
Surface Area of RightSuperiorFrontal Volume (Cortical Parcellation) of LeftRostralMid-
dleFrontal
Cortical Thickness Avg of RightSuperiorFrontal Surface Area of LeftRostralMiddleFrontal
Cortical Thickness STDV of RightSuperiorFrontal Cortical Thickness Avg of LeftRostralMiddle-
Frontal
Volume (Cortical Parcellation) of RightSuperior-
Parietal
Cortical Thickness STDV of LeftRostralMiddle-
Frontal
Surface Area of RightSuperiorParietal Volume (Cortical Parcellation) of LeftSuperior-
Frontal
Cortical Thickness Avg of RightSuperiorParietal Surface Area of LeftSuperiorFrontal
Cortical Thickness STDV of RightSuperiorParietal Cortical Thickness Avg of LeftSuperiorFrontal
Volume (Cortical Parcellation) of RightSuperi-
orTemporal
Cortical Thickness STDV of LeftSuperiorFrontal
Surface Area of RightSuperiorTemporal Volume (Cortical Parcellation) of LeftSuperior-
Parietal
Cortical Thickness Avg of RightSuperiorTemporal Surface Area of LeftSuperiorParietal
Cortical Thickness STDV of RightSuperiorTempo-
ral
Cortical Thickness Avg of LeftSuperiorParietal
Volume (Cortical Parcellation) of RightSupra-
marginal
Cortical Thickness STDV of LeftSuperiorParietal
Surface Area of RightSupramarginal Volume (Cortical Parcellation) of LeftSuperi-
orTemporal
Cortical Thickness Avg of RightSupramarginal Surface Area of LeftSuperiorTemporal
Cortical Thickness STDV of RightSupramarginal Cortical Thickness Avg of LeftSuperiorTemporal
Volume (Cortical Parcellation) of RightTempo-
ralPole
Cortical Thickness STDV of LeftSuperiorTemporal
Surface Area of RightTemporalPole Volume (Cortical Parcellation) of LeftSupra-
marginal
Cortical Thickness Avg of RightTemporalPole Surface Area of LeftSupramarginal
Cortical Thickness STDV of RightTemporalPole Cortical Thickness Avg of LeftSupramarginal
Volume (WM Parcellation) of RightThalamus Cortical Thickness STDV of LeftSupramarginal
Volume (Cortical Parcellation) of RightTransver-
seTemporal
Volume (Cortical Parcellation) of LeftTempo-
ralPole
Surface Area of RightTransverseTemporal Surface Area of LeftTemporalPole
Continued on next page70
Cortical Thickness Avg of RightTransverseTem-
poral
Cortical Thickness Avg of LeftTemporalPole
Cortical Thickness STDV of RightTransverseTem-
poral
Cortical Thickness STDV of LeftTemporalPole
Volume (WM Parcellation) of RightVentralDC Volume (WM Parcellation) of LeftThalamus
Volume (WM Parcellation) of ThirdVentricle Volume (Cortical Parcellation) of LeftTransver-
seTemporal
Volume (Cortical Parcellation) of LeftInsula Surface Area of LeftTransverseTemporal
Surface Area of LeftInsula Cortical Thickness Avg of LeftTransverseTempo-
ral
Cortical Thickness Avg of LeftInsula Cortical Thickness STDV of LeftTransverseTem-
poral
Cortical Thickness STDV of LeftInsula Volume (WM Parcellation) of LeftVentralDC
Volume (WM Parcellation) of LeftAmygdala Volume (WM Parcellation) of OpticChiasm
Volume (Cortical Parcellation) of RightInsula Volume (WM Parcellation) of RightAmygdala
Surface Area of RightInsula Volume (Cortical Parcellation) of RightBankssts
Cortical Thickness Avg of RightInsula Surface Area of RightBankssts
Cortical Thickness STDV of RightInsula Cortical Thickness Avg of RightBankssts
Volume (Cortical Parcellation) of LeftBankssts Cortical Thickness STDV of RightBankssts
Surface Area of LeftBankssts Volume (Cortical Parcellation) of RightCau-
dalAnteriorCingulate
Cortical Thickness Avg of LeftBankssts Surface Area of RightCaudalAnteriorCingulate
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